Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1CNS 1

Conditions

Retinoblastoma 1Retinal Neoplasms 1Port-Wine Stain 1Neurofibromatosis 1 1Neurofibromatoses 1Hemangioma, Capillary 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lasers × 1 year × Clear all
NCT07183644 2026-06-05

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase NA Suspended
10 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting
133 enrolled
Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡